{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:20:05Z","timestamp":1773721205308,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017958","name":"Health Commission of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.tranon.2021.101299","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:32:16Z","timestamp":1638340336000},"page":"101299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["EIF1A depletion restrains human pituitary adenoma progression"],"prefix":"10.1016","volume":"15","author":[{"given":"Rongxin","family":"Geng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.tranon.2021.101299_bib0001","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.tranon.2021.101299_bib0002","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.tranon.2021.101299_bib0003","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrc926","article-title":"The pathogenesis of pituitary tumours","volume":"2","author":"Asa","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2021.101299_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13023-016-0516-x","article-title":"The risks of overlooking the diagnosis of secreting pituitary adenomas","volume":"11","author":"Brue","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.tranon.2021.101299_bib0005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.tranon.2021.101299_bib0006","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(10)82009-6","article-title":"Pathogenesis of pituitary tumors","volume":"182","author":"Yu","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.tranon.2021.101299_bib0007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jbiosc.2009.11.022","article-title":"Eukaryotic translation initiation factor 1 (eIF1), the inspector of good AUG context for translation initiation, has an extremely bad AUG context","volume":"109","author":"Miyasaka","year":"2010","journal-title":"J. Biosci. Bioeng."},{"issue":"1","key":"10.1016\/j.tranon.2021.101299_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2013.06.019","article-title":"Eukaryotic translation initiation factors in cancer development and progression","volume":"340","author":"Spilka","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2021.101299_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(00)80407-4","article-title":"The eIF1A solution structure reveals a large RNA-binding surface important for scanning function","volume":"5","author":"Battiste","year":"2000","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.tranon.2021.101299_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00441-18","article-title":"Cancer-associated eukaryotic translation initiation factor 1A mutants impair Rps3 and Rps10 binding and enhance scanning of cell cycle genes","volume":"39","author":"Sehrawat","year":"2019","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.tranon.2021.101299_bib0011","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1158\/0008-5472.CAN-16-2224","article-title":"EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas","volume":"77","author":"Etemadmoghadam","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2021.101299_bib0012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.tranon.2021.101299_bib0013","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tranon.2021.101299_bib0014","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31250","article-title":"eIF1A residues implicated in cancer stabilize translation preinitiation complexes and favor suboptimal initiation sites in yeast","volume":"6","author":"Martin-Marcos","year":"2017","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.tranon.2021.101299_bib0015","doi-asserted-by":"crossref","first-page":"e12903","DOI":"10.1111\/cpr.12903","article-title":"Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells","volume":"53","author":"Li","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.tranon.2021.101299_bib0016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12020-018-1762-6","article-title":"Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in thyroid cancer genome atlas (TCGA) in a large series of thyroid cancer","volume":"63","author":"Alzahrani","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.tranon.2021.101299_bib0017","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40618-018-0919-8","article-title":"The role of EIF1AX in thyroid cancer tumourigenesis and progression","volume":"42","author":"Sim\u00f5es-Pereira","year":"2019","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.tranon.2021.101299_bib0018","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-18-0606","article-title":"EIF1AX and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC","volume":"9","author":"Krishnamoorthy","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.tranon.2021.101299_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/ERC-16-0043","article-title":"Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules","volume":"23","author":"Karunamurthy","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2021.101299_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2004.08.002","article-title":"Mammalian cells cycle without the d-type cyclin-dependent kinases Cdk4 and Cdk6","volume":"118","author":"Malumbres","year":"2004","journal-title":"Cell"},{"issue":"51","key":"10.1016\/j.tranon.2021.101299_bib0021","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1038\/sj.onc.1210526","article-title":"Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway","volume":"26","author":"Oleinik","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2021.101299_bib0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14728222.2011.644788","article-title":"Targeting the PI3K signaling pathway in cancer therapy","volume":"16","author":"Bartholomeusz","year":"2012","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321002904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321002904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:21:04Z","timestamp":1761844864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321002904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1936523321002904"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101299","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EIF1A depletion restrains human pituitary adenoma progression","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101299"}}